×

Register now for 4 October 2022 at 3:00pm -

October Investor Forum: Shareholder value in ESG investing
Life Sciences

Cizzle Biotechnology

Cizzle is a medical device company developing a companion diagnostic biomarker for the early detection of lung cancer. The blood test will be used alongside a positive chest scan to confirm presence of lung cancer and reduce the high rate of false positives.

Market: LSE Main

Ticker: CIZ

cizzlebiotechnology.com

Request a meeting

If you'd like to be introduced to the team at Cizzle Biotechnology, get in touch.

Request a meeting